Literature DB >> 24270473

New hydroxamic acid derivatives of fluoroquinolones: synthesis and evaluation of antibacterial and anticancer properties.

Gavara Govinda Rajulu1, Halehatty Seephya Bhojya Naik, Abhilash Viswanadhan, Jayaraman Thiruvengadam, Kondodiyil Rajesh, Sambasivam Ganesh, Hiriyan Jagadheshan, Poonimangadu Koppolu Kesavan.   

Abstract

A series of new hydroxamic acid derivatives (6a-f) at C-3 position of fluoroquinolones were designed and synthesized through multistep synthesis. The design concept involved replacement of the 3-carboxylic acid in fluoquinolones with hydroxamic acid as an acid mimicking group. The synthetic work employed in this work provides a good example for the synthesis of pure hydroxamic acid based fluoroquinolones. The synthesized compounds were characterized by (1)H-NMR, electrospray ionization (ESI)-MS and IR. The new compounds were tested for their in vitro antimicrobial and anti-proliferative activity. Out of the six derivatives, compound 6e exhibited moderate antibacterial activity by inhibiting the growth of Escherichia coli and Klebsiella pneumoniae (MIC: 4.00-8.00 µg/mL). Compounds 6b and 6f displayed good growth inhibition against A549 Lung adenocarcinoma and HCT-116 Colon carcinoma cell lines.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 24270473     DOI: 10.1248/cpb.c13-00797

Source DB:  PubMed          Journal:  Chem Pharm Bull (Tokyo)        ISSN: 0009-2363            Impact factor:   1.645


  2 in total

1.  Dual Inhibition of Topoisomerase II and Tyrosine Kinases by the Novel Bis-Fluoroquinolone Chalcone-Like Derivative HMNE3 in Human Pancreatic Cancer Cells.

Authors:  Yong-Chao Ma; Zhi-Xin Wang; Shao-Ju Jin; Yan-Xin Zhang; Guo-Qiang Hu; Dong-Tao Cui; Jiang-Shuan Wang; Min Wang; Fu-Qing Wang; Zhi-Jun Zhao
Journal:  PLoS One       Date:  2016-10-19       Impact factor: 3.240

Review 2.  Fluoroquinolones' Biological Activities against Laboratory Microbes and Cancer Cell Lines.

Authors:  Ghadeer A R Y Suaifan; Aya A M Mohammed; Bayan A Alkhawaja
Journal:  Molecules       Date:  2022-03-03       Impact factor: 4.411

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.